New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
08:25 EDTROIL, ROIL, PFIE, PFIE, ARSD, ARSD, UUUU, UUUU, SRNE, SRNE, VTEQ, VTEQ, SNWV, SNWV, OPXA, OPXA, CGIX, CGIX, GALT, GALT, OGEN, OGENRedChip Companies to hold a virtual conference
RedChip Virtual Conference to be held on April 23-24 with webcasted company presentations to begin on April 23 at 8:30 am. Webcast Link
News For OGEN;GALT;CGIX;OPXA;SNWV;VTEQ;SRNE;UUUU;ARSD;PFIE;ROIL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
08:09 EDTCGIXCancer Genetics granted patent for FHACT
Subscribe for More Information
October 17, 2014
10:30 EDTPFIEProfire Energy initiated with a Buy at Lake Street
Target $6.
October 16, 2014
07:22 EDTROIL, UUUU, PFIERedChip Companies to hold a virtual conference
Global Online CEO Conference is being held on October 15-16 with webcasted presentations to begin on October 16 at 10 am. Webcast Link
October 15, 2014
07:32 EDTOPXA, CGIX, SNWVRedChip Companies to hold a virtual conference
Subscribe for More Information
October 14, 2014
16:04 EDTSRNESorrento Therapeutics announces positive results from pharmacokinetic data
Subscribe for More Information
October 13, 2014
07:52 EDTCGIXCancer Genetics partners with Columbia University oncology researchers
Cancer Genetics has entered into a research collaboration with Columbia University's Azra Raza, MD, director of the MDS Center and assistant professor of medicine at Columbia University Medical Center, and Siddhartha Mukherjee, MD, PhD, assistant professor of medicine at CUMC, to identify more accurate diagnostic and prognostic markers for myelodysplastic syndromes, as well as novel therapies to target this class of bone marrow cancers. The ultimate goal of the collaboration is to develop personalized therapy for MDS patients and to enable accurate prediction of future treatment needs before patients become resistant to their current therapy or before their MDS progresses to the more aggressive acute myeloid leukemia.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use